Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC3680B in Partly Controlled Atopic Asthma
2011-002816-97Phase 2Completed
- Sponsor
- Pulmagen Therapeutics
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing ADC3680B with Placebo (2 arms). Primary endpoint: Safety and tolerability of ADC3680B over 28 days. Started Aug 2011; status: completed.
02
Drugs
GB001
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-002816-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002816-97.